Prelude Therapeutics, Inc. (PRLD)
4.53
-0.17
(-3.62%)
USD |
NASDAQ |
Apr 27, 16:00
4.53
0.00 (0.00%)
After-Hours: 16:57
Prelude Therapeutics Market Cap : 285.40M for April 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Incyte Corp. | 19.04B |
| Niagen Bioscience, Inc. | 397.20M |
| Immunome, Inc. | 2.656B |
| Sana Biotechnology, Inc. | 869.99M |
| Moderna, Inc. | 19.31B |
Market Cap Related Metrics
| PS Ratio | 27.15 |
| Price to Book Value | 4.158 |
| Price | 4.53 |
| Earnings Yield | -29.88% |